ClinicalTrials.gg
Drug

Colesevelam clinical trials

Also written Welchol, IW-3718 and Cholestagel.

studies test it
51
open now
4
in phase 3
13
first study started
2001

How each study uses colesevelam is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the colesevelam studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 May 2000 · WELCHOL · NDA 021141 (FDA, Drugs@FDA)
European Union
9 Mar 2004 · Cholestagel · EMEA/H/C/000512 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Colesevelam
26
Colesevelam hydrochloride
7
Colesevelam HCl
7
Lodalis
2

Brand

Welchol
15
Cholestagel
3

Development codes

IW-3718
5

Studies by the year they started

51 studies that test it; most in 2009 (6)

Studies that test colesevelam, by start year
YearStudies
20011
20021
20031
20044
20053
20061
20075
20081
20096
20104
20111
20122
20143
20151
20166
20171
20184
20192
20241
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
4
Phase 2
12
Phase 3
13
Phase 4
19
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 23 · Other 28

Daiichi Sankyo (15) · Mayo Clinic (6) · Ironwood Pharmaceuticals, Inc. (5) · Hvidovre University Hospital (3) · University Hospital, Gentofte, Copenhagen (3) · Filip Krag Knop (2) · Genzyme, a Sanofi Company (2) · Lars Kristian Munck (1)

Often tested with

Tested in the same studies.

Metformin (3) · Chenodeoxycholic Acid (2) · Clonidine (1) · Niacin (1) · Liraglutide (1) · Thyroxine (1) · Glyburide (1) · Fenofibrate (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test colesevelam.

Studies

Open first, then newest update. How each study uses colesevelam is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 51

See all 51 studies that test colesevelam →

Given beside what is tested · 2 — colesevelam is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with colesevelam

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call colesevelam · ClinicalTrials.gg INT006596

  • MeSH (NLM) D000069472Colesevelam HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 1XU104G55NCOLESEVELAMConfirmed FDA, NLM, Wikidata
  • RxNorm 141626Confirmed FDA, Wikidata
  • Wikidata Q899036colesevelamConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C78056ColesevelamConfirmed FDA, Wikidata
  • DrugBank DB00930One source Wikidata

Also registered as colesevelam hydrochloride (UNII P4SG24WI5Q · RxNorm 141625).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.